X
20
Dongkook Pharmaceutical Co., Ltd. Seoul Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Teicoplanin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-335 - Rev 04
This Chemical Type CEP, issued on October 19, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2358 associated with this CEP further emphasizes